Protein Delivery Reagent Helps Unlock Mechanism of How Toxin Enters Cells
Hits:10 Date: 11/18/2026
The BioPORTER® Protein Delivery Reagent from Amsbio is a specialized lipid-based reagent designed to transport active, fully functional proteins, antibodies, and macromolecules directly into living cells.
Phenomycin is a bacterial mini protein toxin isolated from Streptomyces strains - increasingly used in molecular and cell biology research as a tool to study eukaryotic translation initiation and cellular uptake mechanics.
In a recent published study – researchers from the University of Aarhus, Denmark describe how they used BioPORTER® for intracellular delivery of phenomycin into living cells. This study investigated how the toxin enters cells, revealing that endosomal escape is the primary toxicity-limiting step in its cellular uptake mechanism. As a result of this work – Aarhus University researchers also identified a peptide segment, which constitutes one of two loops in the structure that is critical for the toxicity of phenomycin. This work provides further insights into cellular uptake mechanism for large peptides and proteins, which could unlock new targeting approaches for biologics treatments of the future.
Fluorescently labelled cells
BioPORTER® is highly effective in delivering a diverse array of proteins, peptides, and other macromolecules into the cytoplasm of many different cells, retaining the structure of the proteins whilst leaving the transduced cells unharmed. Using a unique lipid-based protein delivery system – BioPORTER® makes studying protein functionality faster and easier than ever before. Comprising a proprietary cationic lipid mixture that interacts non-covalently with the protein, BioPORTER® creates a protective vehicle for immediate protein delivery directly into the cell cytoplasm. Available either as a bulk reagent or convenient single-use QuikEase™ vials – BioPORTER® is extremely easy to use.
Amsbio, part of the Europa Biosite group, is a leading life sciences company supporting drug discovery, translational research, and cell and gene therapy across Europe, North America, and wider international markets. With in depth expertise in advanced cell culture, 3D cell models, and cryopreservation, Amsbio is well placed to help researchers progress from early discovery through to clinical and GMP-ready applications. The company’s portfolio of innovative products and services supports multiple stages of the research pipeline, spanning target discovery, assay development, and disease modelling, through to stem cell and organoid-based research. Key solutions include the integrated stem cell platform combining StemFit™ media, iMatrix™ recombinant laminins, and CELLBANKER™ cryopreservation technology, alongside extracellular matrix technologies, biospecimens, glycobiology.
---------------------
Worldwide HQ
AMS Biotechnology Europe Ltd (Amsbio)
2-3, Munro House
Trafalgar Way
Bar Hill
Cambridge, CB23 8SQ
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web: www.amsbio.com
North American HQ
Amsbio LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web: www.amsbio.com